Space investing: Europe’s growing space sector
Investors Business Daily | June 2, 2023

Raghav Mittal, Assistant Director, Acuity Knowledge Partners’ recently spoke to Investors.com, a platform for individual and professional investors. He speaks about the growing trend of large pharmaceutical companies acquiring smaller biotech companies with promising oncology or immunology programs.
‘Acquisitions of biotech companies working on oncology or immunology treatments could be worth $5 billion to $25 billion a pop’, he explains.
Latest News

Private Markets Gear Up for 2025 Deal Surge with Tech-first Mindset
Read More
In Hot Credit Market, Fixed-Maturity Funds Are Booming
AT1 Funds, European Bank, Fixed- Maturity Funds
Read More
Seek Outside Help to Accelerate Growth and Improve Efficiency in Commercial Banking
Bank Operations, Inflationary Pressures, Interest Rates
Read More
Shaping the Future of Financial Services: Insights and Leadership Strategies from Acuity Knowledge Partners
Read More
How Robust Domestic Economy Propels Indian Equity Markets To New Highs?
Domestic Liquidity, Economic Growth, Equity Markets
Read More